BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 122622)

  • 1. Galactosyl transferase in benign and neoplastic human bladder mucosa.
    Hagen-Cook K; Prout GR; Plotkin GM; Gilbert SL; Wolf G
    Surg Forum; 1978; 29():627-9. PubMed ID: 122622
    [No Abstract]   [Full Text] [Related]  

  • 2. Galactosyl transferase activity in human transitional cell carcinoma lines and in benign and neoplastic human bladder epithelium.
    Plotkin GM; Wides RJ; Gilbert SL; Wolf G; Hagen IK; Prout GR
    Cancer Res; 1979 Oct; 39(10):3856-60. PubMed ID: 476621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galactosyl transferase activity in rat bladder transitional cell carcinoma lines and in exfoliated cells in urine during carcinogenesis and reversible hyperplasia.
    Plotkin GM; Gilbert SL; Wides RJ; Wolf G; Cohen SM; Fukushima S
    Cancer Biochem Biophys; 1980; 4(4):251-6. PubMed ID: 6778604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood group ABO-related glycosylation of urothelial cell lines: immunocytological, enzymatic, and genetic characterization.
    Meldgaard P; Holmes EH; Bennett EP; Clausen H; Zeuthen J; Wolf H; Orntoft TF
    Cancer Res; 1994 May; 54(9):2440-7. PubMed ID: 8162594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galactosyltransferase activities in cultured urinary bladder tumor cells.
    Gmeiner BM; Wolf G
    Cancer Biochem Biophys; 1985 Dec; 8(2):103-18. PubMed ID: 3936613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of protein kinase C isoenzyme expression in transitional cell carcinoma of bladder. Relation to degree of malignancy.
    Langzam L; Koren R; Gal R; Kugel V; Paz A; Farkas A; Sampson SR
    Am J Clin Pathol; 2001 Sep; 116(3):377-85. PubMed ID: 11554166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes.
    Lee DH; Yang SC; Hong SJ; Chung BH; Kim IY
    Clin Cancer Res; 1998 Mar; 4(3):535-8. PubMed ID: 9533519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commentary on metalloproteinases and bladder carcinoma.
    Liu BC
    J Urol; 1998 Oct; 160(4):1219. PubMed ID: 9751322
    [No Abstract]   [Full Text] [Related]  

  • 9. [Expression of cyclooxygenase-2 in human transitional cell bladder carcinomas].
    Zhan J; Tang XD
    Ai Zheng; 2002 Nov; 21(11):1212-6. PubMed ID: 12526218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Orotate phosphoribosyl transferase in bladder cancer].
    Furuse H; Hirano Y; Harada M; Mugiya S; Ushiyama T; Suzuki K; Ozono S
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1431-3. PubMed ID: 15446572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staining of bladder tumor cell dehydrogenase.
    Kawamura N
    Tokai J Exp Clin Med; 1980 Oct; 5(4):421-33. PubMed ID: 6166091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cell-associated and soluble galactosyltransferase isoenzymes from a human bladder transitional cell carcinoma line.
    Gmeiner B; Wolf G
    Cancer Res; 1987 May; 47(9):2311-6. PubMed ID: 3105874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in adenylate cyclase activities in murine normal cells and bladder tumor cells in tissue culture.
    Droller MJ
    Invest Urol; 1976 Nov; 14(3):249-52. PubMed ID: 186432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of matrix metalloproteinases in human transitional cell carcinoma of the urinary bladder.
    Sumi T; Yoshida H; Hyun Y; Yasui T; Matsumoto Y; Hattori K; Sugimura K; Kawashima H; Nakatani T; Ishiko O
    Oncol Rep; 2003; 10(2):345-9. PubMed ID: 12579270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of DNA topoisomerase I gene and collateral sensitivity to camptothecin in human cisplatin-resistant bladder cancer cells.
    Kotoh S; Naito S; Yokomizo A; Kumazawa J; Asakuno K; Kohno K; Kuwano M
    Cancer Res; 1994 Jun; 54(12):3248-52. PubMed ID: 8205547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of protein kinase C-alpha in superficial bladder carcinoma recurrence.
    Kong C; Zhu Y; Liu D; Yu M; Li S; Li Z; Sun Z; Liu G
    Urology; 2005 Jun; 65(6):1228-32. PubMed ID: 15922420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New experimental models for the in vitro reconstitution of human bladder mucosa.
    De Angeli S; Del Pup L; Fandella A; Di Liddo R; Anselmo G; Macchi C; Conconi MT; Parnigotto PP; Nussdorfer GG
    Int J Mol Med; 2004 Sep; 14(3):367-72. PubMed ID: 15289887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary type IV collagenase: elevated levels are associated with bladder transitional cell carcinoma.
    Margulies IM; Höyhtyä M; Evans C; Stracke ML; Liotta LA; Stetler-Stevenson WG
    Cancer Epidemiol Biomarkers Prev; 1992; 1(6):467-74. PubMed ID: 1302559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutathione S-transferase T1-1 activity upregulated in transitional cell carcinoma of urinary bladder.
    Simic T; Mimic-Oka J; Savic-Radojevic A; Opacic M; Pljesa M; Dragicevic D; Djokic M; Radosavljevic R
    Urology; 2005 May; 65(5):1035-40. PubMed ID: 15882759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of activated matrix metalloproteinase 2 (MMP2) in progression of bladder transitional cell carcinoma].
    Zhang XP; Zhou FJ; Shen PF; Zhou C; Wei JX
    Ai Zheng; 2003 Jun; 22(6):637-9. PubMed ID: 12948424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.